Brazil’s Raia Drogasil Pharmacy Profit Up 9%
RD Saúde, owner of Brazil's Raia and Drogasil pharmacies, earned about US$80 million in Q3 2026, up 9.2%, as online sales rose 27%. The post Brazil’s Raia Drogasil Pharmacy Profit Up 9% appeared first on The Rio Times .
RD Saúde, formerly known as Raia Drogasil, reported a 9.2% increase in adjusted net income to 439.1 million reais (about US$80 million) in the third quarter of 2026, driven by a 16% rise in gross revenue to 13.16 billion reais (about US$2.41 billion). The company sold its specialty-medicine business, 4Bio, which boosted profit from that sale, leading to a 20.1% profit growth excluding 4Bio's performance.
The pharmacy chains, including Raia and Drogasil, saw an increase in digital sales, accounting for 29.4% of retail revenue and growing 27.2%. RD Saúde ended September with 3,770 pharmacies, up from 3,453 a year earlier. Adjusted net debt fell by 15.4% to 2.94 billion reais (about US$538 million). Despite the strong numbers, analysts' consensus for earnings per share was slightly lower, and the long-term impact of online sales growth remains uncertain.
Written by urgent.news from The Rio Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
